Clinical trial
Post Market Clinical Follow-up Study of the Precise Pro Rx Nitinol Stent System in the Treatment of Carotid Artery Disease (REAL-PRECISE)
NCT07204678 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Market Clinical Follow-up Study of the Precise Pro Rx Nitinol Stent System in the Treatment of Carotid Artery Disease (REAL-PRECISE)
- Lead sponsor
- Cordis US Corp.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 30, 2025
- Completion date
- February 27, 2026
- Enrollment
- 199 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
carotid artery stenosis